Chemoinformaics analysis of Methyl 2-methyloctanoate
Molecular Weight | 172.268 | nRot | 6 |
Heavy Atom Molecular Weight | 152.108 | nRig | 16 |
Exact Molecular Weight | 172.146 | nRing | 0 |
Solubility: LogS | -2.894 | nHRing | 0 |
Solubility: LogP | 2.46 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 31.6399 |
nHD | 0 | BPOL | 22.6681 |
QED | 0.771 |
Synth | 3.651 |
Natural Product Likeliness | 0.6 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.754 |
Pgp-sub | 0.134 |
HIA | 0.005 |
CACO-2 | -4.627 |
MDCK | 0.0000386 |
BBB | 0.978 |
PPB | 0.35295 |
VDSS | 1.064 |
FU | 0.309591 |
CYP1A2-inh | 0.053 |
CYP1A2-sub | 0.24 |
CYP2c19-inh | 0.039 |
CYP2c19-sub | 0.929 |
CYP2c9-inh | 0.014 |
CYP2c9-sub | 0.529 |
CYP2d6-inh | 0.926 |
CYP2d6-sub | 0.859 |
CYP3a4-inh | 0.043 |
CYP3a4-sub | 0.853 |
CL | 10.227 |
T12 | 0.857 |
hERG | 0.804 |
Ames | 0.007 |
ROA | 0.025 |
SkinSen | 0.36 |
Carcinogencity | 0.062 |
EI | 0.011 |
Respiratory | 0.938 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.902474 |